Market Access News | pharmaphorum

News

The shake-up of NHS England looks like it could go up a notch, as reports suggest thousands of job cuts that could halve its headcount are planned.

News

AstraZeneca and Ionis add an EU green light to earlier approvals in the US and UK for ATTR polyneuropathy drug Wainzua, a potential blockbuster.

News

Neurotech Pharma's cell therapy Encelto has become the first FDA-approved therapy for idiopathic macular telangiectasia type 2.

News

President Trump's pick to lead the FDA, Martin Makary, was challenged on vaccines, the abortion pill, and FDA staffing decisions at a Senate hearing.

News

Eisai and Biogen have another chance to convince NICE that the NHS should cover the cost of Alzheimer's therapy Leqembi.

News

FDA starts a review of Roche's Gazyva as a treatment for lupus nephritis, an indication that analysts think could unlock renewed sales growth.